Effects of AT1-and β-adrenergic receptor antagonists on TGF-β1-induced fibrosis in transgenic mice

被引：27

作者：

Seeland, U. ^{[1
]}

Schaeffer, A. ^{[1
]}

Selejan, S. ^{[1
]}

Hohl, M. ^{[1
]}

Reil, J. -C. ^{[1
]}

Mueller, P. ^{[1
]}

Rosenkranz, S. ^{[2
]}

Boehm, M. ^{[1
]}

机构：

[1] Univ Klinikum Saarlandes, Innere Med Klin 3, D-66421 Homburg, Germany

[2] Univ Cologne, Innere Med Klin 3, D-50924 Cologne, Germany

来源：

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | 2009年 / 39卷 / 10期

关键词：

Cardiac remodelling; hypertrophy; interstitial remodelling; transforming growth factor beta-1; transgenic mouse model; TRANSFORMING GROWTH FACTOR-BETA(1); RAT CARDIAC FIBROBLASTS; ANGIOTENSIN-II; TGF-BETA; MYOCARDIAL FIBROSIS; INDUCED HYPERTROPHY; GROWTH-FACTOR-BETA-1; EXPRESSION; INHIBITOR; MYOCYTES;

D O I：

10.1111/j.1365-2362.2009.02183.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P>Background Transforming growth factor-beta 1 (TGF-beta 1) is involved in interstitial remodelling promoting collagen synthesis and suppressing collagen degradation by inhibition of collagenases. TGF-beta 1 mediates angiotensin II-dependent effects and modulates beta 1-adrenergic signalling. To study the effect of neuroendocrine antagonism on TGF-beta-induced hypertrophic and fibrotic phenotype, we treated TGF-beta 1 (Cys223,225Ser) transgenic mice (TGF-beta 1-TG) with either the beta 1-receptor blocker metoprolol (MET), the angiotensin II type I (AT1)-receptor antagonist telmisartan (TEL) or an antibody blocking TGF-beta 1 signalling (TGF beta 1-sR-Ab). Material and Methods Transforming growth factor-beta 1-TG mice (8 weeks) overexpressing TGF-beta 1 were treated with either TEL (10 mg kg-1), MET (350 mg kg-1) or a soluble TGF-beta 1 receptor antibody (1 mg kg-1) for 6 weeks. Morphological analyses of interstitium and cardiomyocytes were related to expression of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) by immunoblotting and zymography. Results In TGF-beta 1-TG mice, myocardial interstitial total collagen content was fourfold elevated compared to that of controls (P < 0 center dot 05) and was lowered under the treatment with TEL (P < 0 center dot 05). Protein expression of TIMP-1 and -4 was increased in TGF-beta 1-TG but inhibited by TEL (TIMP-1 and TIMP-4) and MET (TIMP-1), while collagenase activity was decreased in TGF-beta 1-TG and normalized by treatment with TEL (MMP-1 and MMP-13) and MET (MMP-1) (P < 0 center dot 05). Morphometric measurements of cardiomyocyte diameter and area demonstrated similar antihypertrophic effects for all treatment groups. Conclusion The AT1-antagonist TEL reduced myocardial hypertrophy and interstitial fibrosis in TGF-beta 1-TG mice by normalizing MMP/TIMP ratio. beta 1-Adrenergic inhibition by MET as well as TGF-beta 1 antagonism induced antihypertrophic rather than antifibrotic effects. Inhibition of both renin-angiotensin system and beta 1-adrenergic system may exert different but synergistic effects to reduce myocardial remodelling.

引用

页码：851 / 859

页数：9

共 42 条

[11] TGF-BETA MODULATES THE SYNTHESIS OF PROTEOGLYCANS BY MYOCARDIAL FIBROBLASTS IN CULTURE [J].

HEIMER, R ;

BASHEY, RI ;

KYLE, J ;

JIMENEZ, SA .

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1995, 27 (10) :2191-2198

[12] TRANSFORMING GROWTH-FACTOR-BETA-1 MODULATES THE NUMBER OF BETA-ADRENERGIC RECEPTORS IN CARDIAC FIBROBLASTS [J].

IIZUKA, K ;

SANO, H ;

KAWAGUCHI, H ;

KITABATAKE, A .

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1994, 26 (04) :435-440

[13] Transforming growth factor-β1 inhibits the growth of primary adult rat hepatocyte cultures by increasing cAMP levels [J].

Kimura, M ;

Ogihara, M .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 386 (2-3) :271-277

[14] Angiotensin II directly increases transforming growth factor β1 and osteopontin and indirectly affects collagen mRNA expression in the human heart [J].

Kupfahl, C ;

Pink, D ;

Friedrich, K ;

Zurbrügg, HR ;

Neuss, M ;

Warnecke, C ;

Fielitz, J ;

Graf, K ;

Fleck, E ;

Regitz-Zagrosek, V .

CARDIOVASCULAR RESEARCH, 2000, 46 (03) :463-475

[15] TGFβ, cardiac fibroblasts, and the fibrotic response [J].

Leask, Andrew .

CARDIOVASCULAR RESEARCH, 2007, 74 (02) :207-212

[16] ANGIOTENSIN-II STIMULATES THE AUTOCRINE PRODUCTION OF TRANSFORMING GROWTH-FACTOR-BETA-1 IN ADULT-RAT CARDIAC FIBROBLASTS [J].

LEE, AA ;

DILLMANN, WH ;

MCCULLOCH, AD ;

VILLARREAL, FJ .

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1995, 27 (10) :2347-2357

[17] Imatinib mesylate attenuates fibrosis in coxsackievirus B3-induced chronic myocarditis [J].

Leipner, Carola ;

Gruen, Katja ;

Mueller, Andreas ;

Buchdunger, Elisabeth ;

Borsi, Laura ;

Kosmehl, Hartwig ;

Berndt, Alexander ;

Janik, Tobias ;

Uecker, Andrea ;

Kiehntopf, Michael ;

Boehmer, Frank-D. .

CARDIOVASCULAR RESEARCH, 2008, 79 (01) :118-126

[18] Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction [J].

Lonn, E ;

Shaikholeslami, R ;

Yi, QL ;

Bosch, J ;

Sullivan, B ;

Tanser, P ;

Magi, A ;

Yusuf, S .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) :2200-2206

[19]

LOWRY OH, 1951, J BIOL CHEM, V193, P265

[20] Gene expression in fibroblasts and fibrosis - Involvement in cardiac hypertrophy [J].

Manabe, I ;

Shindo, T ;

Nagai, R .

CIRCULATION RESEARCH, 2002, 91 (12) :1103-1113

← 1 2 3 4 5 →